Puma Biotechnology | PBYI - Interest Income


Puma Biotechnology reported $0.41 in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
Agios Pharmaceuticals USD 12.41M 959K Dec/2025
Alnylam Pharmaceuticals USD 26.63M 2.05M Dec/2025
Biogen USD 37.9M 700K Mar/2026
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Daiichi Sankyo JPY 9.96B 230M Mar/2024
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Exelixis USD 16.13M 1.3M Mar/2026
Gilead Sciences USD 95M 7M Dec/2025
Glaxosmithkline GBP 26M 24M Sep/2025
Incyte USD 33.69M 2.93M Mar/2026
MacroGenics USD 1.53M 114K Sep/2025
Moderna USD 70M 3M Dec/2025
Pfizer USD 115M 51M Mar/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 193.3M 18.2M Dec/2025
Sarepta Therapeutics USD 8.74M 359K Dec/2025
Takeda JPY 87.87B 43.48B Dec/2025
Ultragenyx Pharmaceutical USD 6.51M 649K Dec/2025
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026